Advancing Precision Treatment for Multiple Myeloma
ICRF-funded scientist Prof. Ido Amit and his team at the Weizmann Institute are uncovering new insights into multiple myeloma. By analyzing cancer cells from patients, they identified patterns linked to treatment resistance and a potential new target for CAR T-cell therapy. The findings, published in the journal Nature Genetics, could lead to more precise treatments
